BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29485147)

  • 21. pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
    Yan T; Cheng J; Liu Z; Cheng F; Wei X; He J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():442-448. PubMed ID: 29121617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multistimuli-Regulated Photochemothermal Cancer Therapy Remotely Controlled via Fe5C2 Nanoparticles.
    Yu J; Ju Y; Zhao L; Chu X; Yang W; Tian Y; Sheng F; Lin J; Liu F; Dong Y; Hou Y
    ACS Nano; 2016 Jan; 10(1):159-69. PubMed ID: 26602632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid-triggered synergistic chemo-photodynamic therapy systems based on metal-coordinated supramolecular interaction.
    Wang J; Liu L; Yin L; Chen L
    J Biomed Mater Res A; 2018 Nov; 106(11):2955-2962. PubMed ID: 30260555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NIR-Laser-Controlled Drug Release from DOX/IR-780-Loaded Temperature-Sensitive-Liposomes for Chemo-Photothermal Synergistic Tumor Therapy.
    Yan F; Duan W; Li Y; Wu H; Zhou Y; Pan M; Liu H; Liu X; Zheng H
    Theranostics; 2016; 6(13):2337-2351. PubMed ID: 27877239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-Cell-Activated Photodynamic Therapy Assisted by Cu(II)-Based Metal-Organic Framework.
    Wang Y; Wu W; Liu J; Manghnani PN; Hu F; Ma D; Teh C; Wang B; Liu B
    ACS Nano; 2019 Jun; 13(6):6879-6890. PubMed ID: 31194910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nano-Carriers of Combination Tumor Physical Stimuli-Responsive Therapies.
    Jin W; Dong C; Yang D; Zhang R; Jiang T; Wu D
    Curr Drug Deliv; 2020; 17(7):577-587. PubMed ID: 32448102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hyaluronic acid nanogel for photo-chemo theranostics of lung cancer with simultaneous light-responsive controlled release of doxorubicin.
    Khatun Z; Nurunnabi M; Nafiujjaman M; Reeck GR; Khan HA; Cho KJ; Lee YK
    Nanoscale; 2015 Jun; 7(24):10680-9. PubMed ID: 26030737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH-sensitive prodrug conjugated polydopamine for NIR-triggered synergistic chemo-photothermal therapy.
    Zhang H; Sun Y; Huang R; Cang H; Cai Z; Sun B
    Eur J Pharm Biopharm; 2018 Jul; 128():260-271. PubMed ID: 29733952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanolongan with Multiple On-Demand Conversions for Ferroptosis-Apoptosis Combined Anticancer Therapy.
    Bao W; Liu X; Lv Y; Lu GH; Li F; Zhang F; Liu B; Li D; Wei W; Li Y
    ACS Nano; 2019 Jan; 13(1):260-273. PubMed ID: 30616348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication of multifunctional SiO2@GN-serum composites for chemo-photothermal synergistic therapy.
    Liu Y; Bai J; Jia X; Jiang X; Guo Z
    ACS Appl Mater Interfaces; 2015 Jan; 7(1):112-21. PubMed ID: 25474753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.
    Chang JE; Yoon IS; Sun PL; Yi E; Jheon S; Shim CK
    J Photochem Photobiol B; 2014 Nov; 140():49-56. PubMed ID: 25090224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
    Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
    Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photosensitizing hollow nanocapsules for combination cancer therapy.
    Son KJ; Yoon HJ; Kim JH; Jang WD; Lee Y; Koh WG
    Angew Chem Int Ed Engl; 2011 Dec; 50(50):11968-71. PubMed ID: 22006833
    [No Abstract]   [Full Text] [Related]  

  • 34. Sequentially self-assembled polysaccharide-based nanocomplexes for combined chemotherapy and photodynamic therapy of breast cancer.
    Wang Y; Yang M; Qian J; Xu W; Wang J; Hou G; Ji L; Suo A
    Carbohydr Polym; 2019 Jan; 203():203-213. PubMed ID: 30318205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme-triggered deshielding of nanoparticles and positive-charge mediated lysosomal escape for chemo/photo-combination therapy.
    Zhang XQ; Cai SS; He YM; Zhang M; Cao J; Mei H; Li S; He B
    J Mater Chem B; 2019 Aug; 7(31):4758-4762. PubMed ID: 31389948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
    Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
    Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin-conjugated CuS nanoparticles for efficient synergistic therapy triggered by near-infrared light.
    Bi H; Dai Y; Lv R; Zhong C; He F; Gai S; Gulzar A; Yang G; Yang P
    Dalton Trans; 2016 Mar; 45(12):5101-10. PubMed ID: 26883928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Light-Triggered Drug Release from 3D-Printed Magnetic Chitosan Microswimmers.
    Bozuyuk U; Yasa O; Yasa IC; Ceylan H; Kizilel S; Sitti M
    ACS Nano; 2018 Sep; 12(9):9617-9625. PubMed ID: 30203963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomimetic membrane-conjugated graphene nanoarchitecture for light-manipulating combined cancer treatment in vitro.
    Qin C; Fei J; Cai P; Zhao J; Li J
    J Colloid Interface Sci; 2016 Nov; 482():121-130. PubMed ID: 27497233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.